Abstract
The pharmacological effect of FR177391, isolated from Serratia liquefaciens No. 1821, was studied in normal animals and various types of animal models of hypertriglyceridemia. Treatment of normal mice with FR177391 resulted in an increase in heparin-releasable lipoprotein lipase (LPL) activity in the blood and epididymal fat tissue. FR177391 treatment decreased triglyceride (TG) and increased high-density lipoprotein cholesterol in the blood in normal rats following 7 days treatment, suggesting potent LPL activating properties of FR177391. Both Triton WR1339-induced severe and fructose-induced mild hypertriglyceridemia in rats were attenuated by FR177391 treatment. Severely elevated levels of TG in db/db mice, an insulin resistant diabetic animal model, also significantly decreased from 14 days of treatment with FR177391. FR177391 treatment for 9 days caused a decrease in the elevated levels of TG in mice induced by intraperitoneal inoculation of murine lymphoma EL-4. Overall, this study demonstrated that FR177391 can be possibly a LPL activating agent and that FR177391 treatment improved hypertriglyceridemia in various rat and mouse animal models. These results suggest that FR177391 is a promising candidate compound for the management of hypertriglyceridemia.
Similar content being viewed by others
Article PDF
References
Sato B, Nakajima H, Fujita T, Takase S, Yoshimura S, Kinoshita T, Terano H . FR177391, a new lipoprotein lipase activating agent from Serratia. I. Taxonomy, fermentation, isolation, physico-chemical properties, structure elucidation and biological activities. J Antibiot 58: 634–639 ( 2005)
Hauner H, Entenmann G, Wabitsch M, Gaillard D, Ailhaud G, Negrel R, Pfeiffer EF . Promoting effect of glucocorticoids on the differentiation of human adipocyte precursor cells cultured in a chemically defined medium. J Clin Invest 84: 1663–1670 ( 1989)
Tsutsumi K, Inoue Y, Shima A, Iwasaki K, Kawamura M, Murase T . The novel compound NO-1886 increases lipoprotein lipase activity with resulting elevation of high density lipoprotein cholesterol, and long-term administration inhibits atherogenesis in the coronary arteries of rats with experimental atherosclerosis. J Clin Invest 92: 411–417 ( 1993)
Tsutsumi K, Inoue Y, Shima A, Murase T . Correction of hypertriglyceridemia with low high-density lipoprotein cholesterol by the novel compound NO-1886, a lipoprotein lipase-promoting agent, in STZ-induced diabetic rats. Diabetes 44: 414–417 ( 1995)
Tsutsumi K, Inoue Y, Hagi A, Murase T . The novel compound NO-1886 elevates plasma high-density lipoprotein cholesterol levels in hamsters and rabbits by increasing lipoprotein lipase activity without any effect on cholesteryl ester transfer protein activity. Metabolism 46: 257–260 ( 1997)
Chiba T, Miura S, Sawamura F, Uetsuka R, Tomita I, Inoue Y, Tsutsumi K, Tomita T . Antiatherogenic effects of a novel lipoprotein lipase-enhancing agent in cholesterol-fed New Zealand white rabbits. Atheroscler Thromb Vasc Biol 17: 2601–2608 ( 1997)
Tsutsumi K, Inoue Y, Murase T . Effects of NO-1886, a lipoprotein lipase promoting agent, on homozygous and heterozygous Watanabe heritable hyperlipidaemic rabbits. Arzneim-Forsch Drug Res 50: 118–121 ( 2000)
Nilsson-Ehle P, Schotz MC . A stable, radioactive substrate emulsion for assay of lipoprotein lipase. J Lipid Res 17: 536–541 ( 1976)
Otway S, Robinson DS . The use of a non-ionic detergent (Triton WR1339) to determine rates of triglyceride entry into the circulation of the rat under different physiological conditions. J Physiol 190: 321–332 ( 1967)
Ishikawa T, Fidge N . Changes in the concentration of plasma lipoproteins and apoproteins following the administration of Triton WR 1339 to rats. J Lipid Res 20: 254–264 ( 1979)
Sleder J, Chen YDI, Cully MD, Reaven GM . Hyperinsulinemia in fructose-induced hypertriglyceridemia in the rat. Metabolism 29: 303–305 ( 1980)
Zavaroni I, Sander S, Scott S, Reaven GM . Effect of fructose feeding on insulin secretion and insulin action in the rat. Metabolism 29: 970–973 ( 1980)
Hwang IS, Ho H, Hoffman BB, Reaven GM . Fructose-induced insulin resistance and hypertension in rats. Hypertension 10: 512–516 ( 1987)
Zavaroni I, Chen YDI, Reaven GM . Studies of the mechanism of fructose-induced hypertriglyceridemia in the rat. Metabolism 31: 1077–1083 ( 1982)
Kobayashi K, Forte TM, Taniguchi S, Ishida BY, Oka K, Chan L . The db/db mouse, a model for diabetic dyslipidemia: molecular characterization and effects of western diet feeding. Metabolism 49: 22–31 ( 2000)
Tsujimoto S, Kawamura I, Inami M, Lacey E, Nishigaki F, Naoe Y, Manda Y, Goto T . Cachexia induction by EL-4 lymphoma in mice and possible involvement of impaired lipoprotein lipase activity. Anticancer Res 20: 3111–3116 ( 2000)
Patsch JR, Gotto AM Jr, Olivecrona T, Eisenberg S . Formation of high density lipoprotein2-like particles during lipolysis of very low density lipoproteins in vitro. Proc Natl Acad Sci USA 75: 4519–4523 ( 1978)
Chung BH, Segrest JP . Cytotoxicity of remnants of triglyceride-rich lipoproteins: an atherogenic insult? Adv Exp Med Biol 285: 341–351 ( 1991)
Weinstock PH, Bisgaier CL, Aalto-Setala K, Radner H, Ramakrishnan R, Levak-Frank S, Essenburg AD, Zechner R, Breslow JL . Severe hypertriglyceridemia, reduced high density lipoprotein, and neonatal death in lipoprotein lipase knockout mice. Mild hypertriglyceridemia with impaired very low density lipoprotein clearance in heterozygotes. J Clin Invest 96: 2555–2568 ( 1995)
Shimada M, Shimano H, Gotoda K, Yamamoto K, Kawamura M, Inaba T, Yazaki Y, Yamada N . Overexpression of human lipoprotein lipase in transgenic mice. Resistance to diet-induced hypertriglyceridemia and hypercholesterolemia. J Biol Chem 268: 17924–17929 ( 1993)
Hara T, Cameron-Smith D, Cooney GJ, Kusunoki M, Tsutsumi K, Storlien LH . The actions of a novel lipoprotein lipase activator, NO-1886, in hypertriglyceridemic fructose-fed rats. Metabolism 47: 149–153 ( 1998)
Malloy MJ, Kane JP . A risk factor for atherosclerosis: triglyceride-rich lipoproteins. Adv Intern Med 47: 111–136 ( 2001)
Rapp RJ . Hypertriglyceridemia: a review beyond low-density lipoprotein. Cardiol Rev 10: 163–172 ( 2002)
Szapary PO, Rader DJ . Pharmacological management of high triglycerides and low high-density lipoprotein cholesterol. Curr Opin Pharmacol 1: 113–120 ( 2001)
Rader DJ, Haffner SM . Role of fibrates in the management of hypertriglyceridemia. Am J Cardiol 83: 30F–35F ( 1999)
Breuer HW . Hypertriglyceridemia: a review of clinical relevance and treatment options: focus on cerivastatin. Curr Med Res Opin 17: 60–73 ( 2001)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Inami, M., Kawamura, I., Tsujimoto, S. et al. FR177391, A New Anti-hyperlipidemic Agent from Serratia. J Antibiot 58, 640–647 (2005). https://doi.org/10.1038/ja.2005.88
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ja.2005.88
Keywords
This article is cited by
-
Isolation of a Novel Lipase Gene from Serratia liquefaciens S33 DB-1, Functional Expression in Pichia pastoris and its Properties
Molecular Biotechnology (2008)
-
FR177391, A New Anti-hyperlipidemic Agent from Serratia
The Journal of Antibiotics (2005)
-
FR177391, A New Anti-hyperlipidemic Agent from Serratia
The Journal of Antibiotics (2005)
-
FR177391, A New Anti-hyperlipidemic Agent from Serratia
The Journal of Antibiotics (2005)